Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 Read more
European Commission approves second indication of Sarclisa (isatuximab) for relapsed multiple myeloma Read more
Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China Read more
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19 Read more
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy Read more